<DOC>
	<DOCNO>NCT00967746</DOCNO>
	<brief_summary>This phase 2 , randomize , active-controlled , parallel-group , multicenter , single-blind trial three different dos etonogestrel release medicate intrauterine system ( ENG-MIUS ) healthy parous woman need contraception . The primary trial objective explore safety acceptability three dose ENG-releasing medicate intrauterine system ( ENG-MIUS ) compare Multiload-cu 375Â® .</brief_summary>
	<brief_title>An Explorative Trial Explore Safety , Acceptability Vaginal Bleeding Pattern Three Etonogestrel-releasing Medicated Intrauterine Systems ( Study P06060 )</brief_title>
	<detailed_description />
	<mesh_term>Uterine Hemorrhage</mesh_term>
	<mesh_term>Etonogestrel</mesh_term>
	<mesh_term>Desogestrel</mesh_term>
	<criteria>Healthy female subject need contraception select participate trial ; Each subject must &gt; =18 &lt; =40 year age screen need contraception ; Each subject must give birth least one child ( gestational age &gt; =28 week ) ; Each subject must uterus measured length 6.0 9.0 cm ( extremes include ) external o fundus uterus . A subject must pregnant suspected pregnant ; A subject must ectopic pregnancy past must history presence predispose factor condition salpingitis , endometritis pelvic peritonitis ; A subject must history presence malignancy ; A subject must history presence premalignant disease uterus cervix , include endometrial hyperplasia , ( ) sexsteroid sensitive premalignancies ; A subject must active venous thromboembolic disorder ( e.g . deep vein thrombosis , pulmonary embolism ) ; A subject must history presence severe hepatic disease AST and/or ALT level &gt; =3 time upper normal limit ; A subject must congenital acquire malformation distortion uterus cervix ; A subject must large multiple uterine fibromyomata , small uterine fibromyoma may interfere insertion MIUS/IUD accord investigator ; A subject must vaginal bleeding undiagnosed etiology ; A subject must dysmenorrhea interfere daily activity menorrhagia</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>